| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
2,987 |
2,693 |
$600K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
843 |
773 |
$113K |
| 80053 |
Comprehensive metabolic panel |
4,083 |
3,422 |
$42K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
1,247 |
1,159 |
$38K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,654 |
1,418 |
$35K |
| 71045 |
Radiologic examination, chest; single view |
1,797 |
1,624 |
$30K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,526 |
3,592 |
$27K |
| 70450 |
Computed tomography, head or brain; without contrast material |
675 |
617 |
$24K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
673 |
613 |
$21K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
184 |
170 |
$18K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
331 |
308 |
$18K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
434 |
398 |
$12K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
867 |
811 |
$8K |
| 84484 |
|
1,401 |
1,126 |
$6K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
59 |
54 |
$6K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
88 |
67 |
$5K |
| 36415 |
Collection of venous blood by venipuncture |
4,831 |
4,115 |
$4K |
| 81001 |
|
1,550 |
1,385 |
$4K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
14 |
13 |
$3K |
| 84703 |
|
658 |
602 |
$3K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
487 |
439 |
$3K |
| 83690 |
|
1,346 |
1,201 |
$3K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
70 |
66 |
$3K |
| 83880 |
|
243 |
214 |
$3K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
267 |
237 |
$1K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
286 |
226 |
$1K |
| 85610 |
|
715 |
652 |
$926.11 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
69 |
65 |
$877.50 |
| 81025 |
|
133 |
119 |
$743.06 |
| 85730 |
|
276 |
254 |
$559.14 |
| 72125 |
Computed tomography, cervical spine; without contrast material |
29 |
26 |
$554.72 |
| 87486 |
|
27 |
26 |
$508.92 |
| 87581 |
|
26 |
25 |
$500.07 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
131 |
112 |
$446.80 |
| 81003 |
|
237 |
223 |
$382.89 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
322 |
254 |
$367.15 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
13 |
12 |
$359.74 |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
12 |
12 |
$329.93 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,041 |
887 |
$289.20 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
14 |
13 |
$288.92 |
| 84702 |
|
32 |
25 |
$250.91 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
529 |
373 |
$163.34 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
1,448 |
931 |
$97.04 |
| 84443 |
Thyroid stimulating hormone (TSH) |
12 |
12 |
$67.71 |
| 87430 |
|
13 |
12 |
$53.64 |
| 85027 |
|
13 |
12 |
$48.33 |
| 83735 |
|
31 |
26 |
$45.81 |
| 86900 |
|
14 |
12 |
$24.58 |
| 86901 |
|
12 |
12 |
$22.20 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
14 |
12 |
$13.89 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
12 |
12 |
$12.31 |
| 82962 |
|
267 |
133 |
$6.16 |